I agree that this site is using cookies. You can find further informations here.
X
Park, Sook Ryun
969  results:
Search for persons X
?
1

Impact of Patient Sex on Adverse Events and Unscheduled Uti..:

Choi, Songji ; Seo, Seyoung ; Lee, Ju Hyun...
Cancer Research and Treatment.  56 (2024)  2 - p. 404-413 , 2024
Link: https://doi.org/10.4143/..
 
?
2

Detection and evaluation of signals for immune-related adve..:

Kim, Eo Jin ; Kim, Ye-Jee ; Heo, Ja Yoon...
Frontiers in Oncology.  13 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Pragmatic nationwide master observational trial based on ge..:

Kim, Sun Young ; Kim, Jee Hyun ; Kim, Tae-Yong...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

Phase II study of nivolumab in patients with genetic altera..:

Kim, Ju Won ; Lee, Hyo Jin ; Lee, Ji Yoon...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008638 , 2024
Link: https://doi.org/10.1136/..
 
?
5

A phase 2 study of spartalizumab (PDR001) among patients wi..:

Lee, Dong Ki ; Park, Sook Ryun ; Kim, Yeul Hong...
OncoImmunology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
6

Integrative modeling of tumor genomes and epigenomes for en..:

Bae, Mingyun ; Kim, Gyuhee ; Lee, Tae-Rim...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Integrative analysis of risk factors for immune-related adv..:

Sung, Changhwan ; An, Jinhyeon ; Lee, Soohyeon...
Nature Cancer.  4 (2023)  6 - p. 844-859 , 2023
Link: https://doi.org/10.1038/..
 
?
8

Clinical outcomes of immune checkpoint inhibitors in unrese..:

Jang, Yoon Jung ; Kim, Eo Jin ; Kim, Hyung-Don...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  10 - p. 7547-7555 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Tislelizumab plus chemotherapy versus placebo plus chemothe..:

Xu, Jianming ; Kato, Ken ; Raymond, Eric...
The Lancet Oncology.  24 (2023)  5 - p. 483-495 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Real-world efficacy and safety of cabozantinib in Korean pa..:

Bang, Yeong Hak ; Lee, Choong-kun ; Yoo, Changhoon...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210979 , 2022
Link: https://doi.org/10.1177/..
 
?
11

Real-World Efficacy Data and Predictive Clinical Parameters..:

Kim, Jwa Hoon ; Ahn, Bokyung ; Hong, Seung-Mo...
Cancer Research and Treatment.  54 (2022)  2 - p. 505-516 , 2022
Link: https://doi.org/10.4143/..
 
?
12

Role of Esophagectomy after Chemoradiation Therapy in Patie..:

Yu, Jesang ; Kim, Jong Hoon ; Kim, Sung-Bae...
Cancer Research and Treatment.  54 (2022)  4 - p. 1148-1156 , 2022
Link: https://doi.org/10.4143/..
 
?
13

Correction to: Efficacy and Safety Results from a Phase 2, ..:

Ryoo, Baek‑Yeol ; Palmer, Daniel H. ; Park, Sook Ryun...
Clinical Drug Investigation.  42 (2022)  3 - p. 283-283 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Efficacy and safety of lenvatinib in patients with recurren..:

Bang, Kyunghye ; Casadei‐Gardini, Andrea ; Yoo, Changhoon...
Cancer Medicine.  12 (2022)  3 - p. 2572-2579 , 2022
Link: https://doi.org/10.1002/..
 
?
15

Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Ac..:

Yoon, Shinkyo ; Yang, Hannah ; Ryu, Hyun-Min...
Cancer Research and Treatment.  54 (2022)  3 - p. 767-781 , 2022
Link: https://doi.org/10.4143/..
 
1-15